WeVote
Log In

Bill

Bill

S 8592

Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children

2025 Regular Session Introduced by Joe Addabbo and 6 co-sponsors

Requires health plans to cover continuous glucose monitors for all children, expanding access to pediatric diabetes care and boosting potential glycemic control.

ORDERED TO THIRD READING RULES CAL.1382
0
WeVote Research Nonpartisan
Bill Summary · S 8592

Summary of S 8592 — Requires health insurance plans to provide coverage for continuous blood glucose monitors for all children

Overview

S 8592 is a Senate bill introduced on November 26, 2025, with the stated aim of requiring health insurance plans to provide coverage for continuous glucose monitors (CGMs) for all children. The bill is currently “Referred to Rules,” indicating it has been placed in a procedural committee for consideration. A companion bill exists in the Assembly, identified as A 6923.

Purpose and intent

  • To ensure that pediatric patients who rely on CGMs have coverage under their health insurance plans.
  • The bill signals a priority on improving access to diabetes management technology for children.

Key provisions (as indicated by the available information)

  • The core and explicit provision is that health insurance plans would be required to provide coverage for continuous glucose monitors for all children.
  • Details such as eligibility age range (e.g., under 18), covered CGM models or accessories, requirements for prior authorization, cost-sharing limits, deductibles, rebates, or network requirements are not specified in the information provided.
  • The summary does not indicate whether the coverage must apply to both state-employee plans and private market plans, nor whether there are any grandfathering provisions for existing policies.

Affected parties

  • Children who utilize CGMs for diabetes management.
  • Health insurance plans and issuers (including private plans and possibly public programs under the state’s purview, though not specified).
  • Families and caregivers of pediatric patients who rely on CGMs.
  • Healthcare providers and suppliers of CGMs, who may experience administrative or reimbursement changes.

Procedural and timeline aspects

  • Introduced: November 26, 2025.
  • Status: Referred to Rules (a procedural step, typically indicating the bill will be reviewed by the Rules committee before moving to additional committees or floor action).
  • Related legislation: Companion bill in the Assembly is A 6923 (listed twice in the related bills).

Potential impact and considerations

  • Population health: If enacted, could improve access to CGMs for children, potentially supporting better glycemic control and reduced diabetes complications over time.
  • Economic: Insurers may need to adjust coverage frameworks, reimbursement rates, and administrative processes; potential cost implications for plans and employers.
  • Implementation: The absence of detailed coverage terms in the provided information means timing, enforcement, and precise scope would depend on the final enacted language and any regulatory guidance.

Next steps for readers

  • Monitor for committee hearings and any amendments to S 8592.
  • Check for updates on the companion A 6923 in the Assembly for parallel progression.
  • Review the final bill text to understand specific definitions, coverage standards, exclusions, and any transition provisions if the bill advances.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.